Log in to save to my catalogue

The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2600288376

The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

About this item

Full title

The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2022-03, Vol.27 (3), p.1435-1447

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Schizophrenia has a multifactorial etiology, involving a polygenic architecture. The potential benefit of whole genome sequencing (WGS) in schizophrenia and other psychotic disorders is not well studied. We investigated the yield of clinical WGS analysis in 251 families with a proband diagnosed with schizophrenia (
N
 = 190), schizoaffective...

Alternative Titles

Full title

The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2600288376

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2600288376

Other Identifiers

ISSN

1359-4184,1476-5578

E-ISSN

1476-5578

DOI

10.1038/s41380-021-01383-9

How to access this item